Bildkälla: Stockfoto

Xbrane Biopharma Q1 – Approaching readout - Redeye

Redeye leaves a comment on Xbrane following today’s release of the report for the first quarter. We retain our positive stance as the company approaches the readout of Xplore.

Redeye leaves a comment on Xbrane following today’s release of the report for the first quarter. We retain our positive stance as the company approaches the readout of Xplore.
Börsvärldens nyhetsbrev
ANNONSER